Eastman Chemical CO Form 4 insider transactions

Eastman Chemical CEO and Board Chair Mark J. Costa acquired 7,400 shares of common stock at $67.89 per share, signaling increased insider confidence.

Director Brett D. Begemann acquired 1,575 phantom stock units of Eastman Chemical Co on May 1, 2025, under the Directors' Deferred Compensation Plan.

Director Julie Fasone Holder received 1,575 shares of Eastman Chemical Co. restricted stock on May 1, 2025, as part of her annual Restricted Stock Award.

Director James J. O'Brien acquired 1,575 shares of Eastman Chemical Co. common stock on May 1, 2025, as part of a restricted stock award.

Director Renee J. Hornbaker reports acquisition of 1,575 restricted shares of Eastman Chemical Co. on May 1, 2025, as part of her annual Restricted Stock Award.

Director Linnie M. Haynesworth reports acquisition and disposal of phantom stock units and deferral of restricted stock award.

Director Kim Ann Mink reports acquisition of 1,575 phantom stock units of Eastman Chemical Co, deferred from a restricted stock award, vesting on May 1, 2026.

Director Humberto P. Alfonso acquired 1,575 phantom stock units of Eastman Chemical Co. under the Directors' Deferred Compensation Plan on May 1, 2025.

Director Eric L. Butler reports acquisition of 1,575 shares of Eastman Chemical Co. restricted stock as part of annual Restricted Stock Award.

Director Donald W. Slager reports acquisition of restricted stock and disposal of common stock in Eastman Chemical Co.

Director Donald W. Slager reports changes in beneficial ownership of Eastman Chemical Co. stock due to phantom stock units credited under the Directors' Deferred Compensation Plan.

Director Julie Fasone Holder reports the acquisition of 412 phantom stock units in Eastman Chemical Co through the Directors' Deferred Compensation Plan.

Director Humberto P. Alfonso reports acquisition of phantom stock units through deferral of director's fees, increasing his holdings in Eastman Chemical Co.

Director Kim Ann Mink reported the acquisition of 412 Phantom Stock Units of Eastman Chemical Co on April 7, 2025, through the Directors' Deferred Compensation Plan.

Director Brett D. Begemann reports acquisition of phantom stock units through director's deferred compensation plan.

Director David W. Raisbeck reports the acquisition of phantom stock units and deferral of retainer fees into Eastman Chemical Co. stock account.

Director Linnie M. Haynesworth acquired 412 phantom stock units in Eastman Chemical Co through a directors' deferred compensation plan.

Director James J. O'Brien reports acquisition of 412 Phantom Stock Units in Eastman Chemical Co under the Directors' Deferred Compensation Plan.

Director Renee J. Hornbaker reports acquiring phantom stock units in Eastman Chemical Co through a directors' deferred compensation plan.

Director Eric L. Butler reports acquisition of phantom stock units and deferral of retainer fees into Eastman Chemical Co. stock account.

EVP & CCO of Eastman Chemical Co., Brad A. Lich, reports gifting 1,750 shares of common stock to a charitable donor-advised fund on March 7, 2025.

Michelle H. Caveness, SVP & Chief Manufacturing Officer of Eastman Chemical Co, exercised stock options and sold shares on March 3, 2025.

Eastman Chemical CEO Mark Costa exercised stock options and sold shares on February 26, 2025, resulting in a net change in his holdings.

Eastman Chemical Co's CFO, William Thomas McLain Jr., reports the acquisition and disposal of company stock and stock options.

Michelle H. Caveness, SVP & Chief Manufacturing Officer of Eastman Chemical Co., reports the acquisition of stock options and restricted stock units.

EVP & CCO of Eastman Chemical Co., Brad A. Lich, reports the acquisition of stock options and restricted stock units.

Bosede Ikeolu Gbadegesin, SVP, CLO & Corporate Secretary of Eastman Chemical Co., reports acquisition of stock options and restricted stock units.

Julie A. McAlindon, SVP at Eastman Chemical Co, reports the acquisition of stock options and restricted stock units.

Brian Travis Smith, an Executive Vice President at Eastman Chemical Co., reported the acquisition of stock options and restricted stock units on February 20, 2025.

Adrian James Holt, SVP, Chf HR Ofcr of Eastman Chemical Co, reports acquisition of common stock, stock options, and restricted stock units.